Rigel Pharmaceuticals RIGL
NASDAQ RIGL
$48.89 -0.47 (-0.95%)
At close: Sep 29, 2026 · 4:00 PM EDT

Rigel Pharmaceuticals (RIGL) Revenue (2010 - 2026)

Updated

Rigel Pharmaceuticals' Revenue was $78.7 million in Q2 2026, down 22.6% from $101.69 million a year earlier but up 33.8% from the prior quarter.

Analysis

Rigel Pharmaceuticals (RIGL) Revenue (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Rigel Pharmaceuticals' Revenue was $276.79 million through Jun 30, 2026, up 3.3% year-over-year; for FY2025, it was $294.28 million, up 64.1% from FY2024.

  • Revenue shows a five-year compound annual growth rate of 22.1% (FY2020 to FY2025).
  • In earlier years, Revenue was $179.28 million in FY2024 (+53.4%), $116.88 million in FY2023 (-2.8%), $120.24 million in FY2022 (-19.4%) and $149.24 million in FY2021 (+37.4%).
  • Quarterly Revenue has moved between $16.74 million (Q1 2022) and $101.69 million (Q2 2025) over five years.
  • Compared with a year earlier, Revenue was higher in seven of the last eight quarters, with growth averaging 56.1%.
  • The best year-over-year quarter for Revenue over five years was Q2 2025 (growth of 176.0%); the worst was Q1 2022 (a decline of 79.3%).
  • Per Business Quant data, RIGL's Revenue in the three quarters before Q2 2026 was $58.82 million (Q1 2026), $69.8 million (Q4 2025) and $69.46 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 25.31 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 16.99 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.38 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 7.80 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.33 Bn
10 Rigel Pharmaceuticals 922.04 Mn 387.93 Mn 70.18 Mn 78.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 78.70 Mn
Mar 31, 2026 58.82 Mn
Dec 31, 2025 69.80 Mn
Sep 30, 2025 69.46 Mn
Jun 30, 2025 101.69 Mn
Mar 31, 2025 53.33 Mn
Dec 31, 2024 57.60 Mn
Sep 30, 2024 55.31 Mn
Jun 30, 2024 36.84 Mn
Mar 31, 2024 29.53 Mn
Dec 31, 2023 35.79 Mn
Sep 30, 2023 28.13 Mn
Jun 30, 2023 26.89 Mn
Mar 31, 2023 26.07 Mn
Dec 31, 2022 51.28 Mn
Sep 30, 2022 22.41 Mn
Jun 30, 2022 29.82 Mn
Mar 31, 2022 16.74 Mn
Dec 31, 2021 20.41 Mn
Sep 30, 2021 21.54 Mn
API Access

Rigel Pharmaceuticals Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=RIGL&period=max&api_key=YOUR_API_KEY